Studies have demonstrated that polydatin can enhance glucose metabolism and uptake while simultaneously decreasing lipid accumulation in insulin-resistant human hepatoma HepG2 cells, indicating its potential as a therapeutic agent in managing metabolic dysfunctions associated with diabetes [13,14]. This evidence concerns the gene INS and diabetes mellitus.